A b s t r a c t -I n t h e p a s t drugs were o f t e n discovered by chance o r by i n f e r r i n g t h e p r o p e r t i e s o f t h e i r macromolecular receptors from painst a k i n g s t r u c t u r e -a c t i v i t y c o r r e l a t i o n s . a r e understood i n atomic d e t a i l both f o r n u c l e i c a c i d s and a number o f important enzymes. t o s t a r t u s i n g t h e o r e t i c a l c a l c u l a t i o n s t o produce d e s i r a b l e s e l e c t i v i t y so as t o d i s t i n g u i s h , f o r example, between cancerous and normal c e l l s .
INTRODUCTION

I f we t r y t o design drugs s t a r t i n g w i t h a knowledge o f t h e receptor a r c h i t e c t u r e , then t h e obvious t a r g e t s a r e n u c l e i c a c i d s o r enzymes. both on i n t e r c a l a t i n g drugs and on groove binders such as t h e l e x i t r o p s i n s . compounds e x c i t e p a r t i c u l a r i n t e r e s t because t h e y a r e t o a marked degree sequence s p e c i f i c :
netropsin, f o r example, b i n d s p r e f e r e n t i a l l y t o sequences which a r e r i c h i n poly(dA) -poly(dT) r a t h e r than poly(dG) -p o l y (dC). Some understanding o f t h i s preference may be derived from d i s p l a y s o f t h e e l e c t r o s t a t i c p o t e n t i a l i n t h e minor grooves o f model systems. These i n d i c a t e t h a t t h e A -T combination g i v e s r i s e t o a p o t e n t i a l more a t t r a c t i v e t o p o s i t i v e species. The hope i s t h a t t h i s w i l l be t h e s t a r t i n g p o i n t f o r t h e design o f drugs which w i l l be s p e c i f i c f o r p r e c i s e sequences o f bases so t h a t oncogenes could be sought o u t and switched o f f , perhaps by methylation.
For p r o t e i n s t h e r e a r e f a r more d e t a i l s o f t h e s t r u c t u r e s o f b i n d i n g s i t e s and a number o f p h y s i o l o g i c a l l y important processes may be blocked by s u i t a b l e i n h i b i t o r s . For some years we have been u s i n g a m o d i f i e d quantum mechanical method t o c a l c u l a t e t h e b i n d i n g energies o f i n h i b i t o r s t o enzymes ( r e f s . 1,2). E s s e n t i a l l y we t r e a t t h e atoms o f t h e enzyme as p o i n t p a r t i a l charges b u t t r e a t t h e small l i g a n d i n a f u l l quantum mechanical manner. I n t h i s way we have, f o r example, been a b l e t o reproduce t h e experimental b i n d i n g energy o f t h e a n t icancer drug methotrexate t o d i h y d r o f o l a t e reductase (DHFR) (see Figure 1 ).
I n t h e case o f DNA i n t e r e s t i s being focussed These l a t t e r
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Methotrexate binds s t r o n g l y t o t h e enzyme, i n t e r f e r i n g w i t h t h e metabolism o f f o l i c a c i d and hence k i l l i n g t h e c e l l , so t h a t r a p i d l y p r o l i f e r a t i n g c e l l s a r e most damaged. normal c e l l s a r e a l s o damaged w i t h t h e r e s u l t t h a t s i d e -e f f e c t s a r e severe. What i s r e q u i r e d i s a drug which w i l l b i n d p r e f e r e n t i a l l y t o cancer c e l l s .
Reynolds e t a l . (Ref. 3 ) provides a p o s s i b l e avenue; s e l e c t i v i t y based on redox p o t e n t i a l .
However A suggestion by
TUMOUR SELECTIVE ANTIFOLATES
Although t h e t a r g e t enzyme (DHFR) i n normal and tumour c e l l s may be i d e n t i c a l , t h e r e a r e o t h e r d i f f e r e n t i a t i n g p r o p e r t i e s . reduced oxygen supply (Ref. 4 ) . 32 mmHg i n normal c e l l s t o 0.25 mmHg i n s o l i d tumours. T h i s prompted t h e suggestion (Ref.
3 ) t h a t i t should be p o s s i b l e t o design compounds which would b i n d t o and i n h i b i t DHFR when they a r e i n t h e reduced form b u t n o t when oxidized.
Figure 2 shows how t h e diamino p t e r i d i n e p o r t i o n o f methotrexate binds t o t h e e s s e n t i a l l y coplanar Asp 27, I l e 5, I l e 94 and H20 635 o f methotrexate. Figure 3 i n d i c a t e s how r e p l a c i n g t h e amino groups by hydroxyls provides an a l t e r n a t i v e which i s s t i l l capable o f hydrogen bonding, w h i l e t h e o x i d i z e d form (Figure 4 ) loses t h i s c a p a c i t y . The design t a s k now becomes one o f a d j u s t i n g t h e redox p o t e n t i a l by means o f s u b s t i t u e n t s so as t o ensure t h a t t h e reduced form should be t h e favoured s t a t e i n t h e tumour c e l l s.
S o l i d tumours i n p a r t i c u l a r a r e hypoxic due t o t h e i r I t has been estimated t h a t oxygen t e n s i o n i s reduced from Some support f o r t h i s approach i s provided by t h e f a c t t h a t quinonoid molecules such as mitomycin C a r e used c l i n i c a l l y , r e l y i n g on enzymic r e d u c t i o n t o a l k y l a t i n g agents. n o t i o n i s t h a t our designed quinonoid DHFR i n h i b i t o r s would be administered w i t h compounds thought t o reduce oxygen supply. s i c k l e -c e l l anaemia p a t i e n t s . compounds given t h e reduced blood supply t o t h e tumours.
Our Compounds w i t h t h e l a t t e r p r o p e r t y were designed f o r The remaining major problem would be t h e d e l i v e r y o f our
TRANSITION STATE ANALOGUES
I f we were l i m i t e d i n designing i n h i b i t o r s t o those enzymes f o r which c r y s t a l s t r u c t u r e s a r e a v a i l a b l e then t h e r e would be v e r y l i m i t e d progress. However t h e o r i g i n a l i d e a o f Pauling (Ref. 5 ) , t h a t enzymes lower t h e energy o f t r a n s i t i o n s t a t e s , leads t o t h e conclusion t h a t many enzymes c o u l d be blocked by t r a n s i t i o n s t a t e analogues. p e n i c i l l i n o r glyphosate e x p l o i t t h i s f a c t . Such major i n h i b i t o r s as
Since t r a n s i t i o n s t a t e s a r e n o t c l a s s i c a l s t r u c t u r e s they a r e n o t s u i t a b l e f o r study by e m p i r i c a l l y parameterized methods such as molecular mechanics. Quantum chemical c a l c u l a t i o n s , p r e f e r a b l y u s i n g g r a d i e n t techniques become e s s e n t i a l . Even so massive amounts o f computer t i m e may be r e q u i r e d when searching f o r t r a n s i t i o n s t a t e s o r intermediates on multidimensional surfaces.
Once a t r a n s i t i o n s t a t e has been l o c a t e d t h e design o f an i n h i b i t o r demands t h e synthesis o f a s t a b l e molecule which mimics t h e unstable o r metastable t r a n s i t i o n a l s t r u c t u r e . I n order t o do t h i s i t i s h e l p f u l t o use q u a n t i t a t i v e measures o f how s i m i l a r any p u t a t i v e i n h i b i t o r i s t o t h e p o s t u l a t e d t r a n s i t i o n s t a t e .
introduced by Carbo (Refs. 6,7) which d e f i n e s t h e s i m i l a r i t y , RAE, between molecules A and B i n terms o f t h e i r charge d e n s i t i e s pA and pB by
Much use has been made o f t h e s i m i l a r i t y index
JpApBdv
(where V i s a volume element and i n t e g r a t i o n i s over a l l space)
This index concentrates on s i m i l a r i t y o f shape o f t h e e l e c t r o n d e n s i t y r a t h e r than magnitude ( i f , f o r example, pA=flp t h e above index would be u n i t y , r e p r e s e n t i n g i d e n t i t y ) . We have proposed an a l t e r n a t i v e ?Ref. 8) I n a d d i t i o n we have used both forms o f index n o t j u s t t o compare e l e c t r o n d e n s i t i e s b u t a l s o e l e c t r o s t a t i c p o t e n t i a l s and e l e c t r o s t a t i c f i e l d s . I n t h e case o f t h e l a t t e r two p r o p e r t i e s t h e index runs from -1 t o +1 and we have computed values numerically, t a k i n g a g r i d o f p o i n t s extending 10A around t h e molecules being compared and e x c l u d i n g t h e van der Waals volumes o f t h e molecules being compared, s i n c e s i n g u l a r i t i e s occur a t nuclear p o s i t i o n s .
The use o f s i m i l a r i t y measures as a means o f designing i n h i b i t o r s o f enzymes can a l s o be used i n t h e reverse f a s h i o n -producing enzymes i n t h e form o f a n t i b o d i e s .
A l o n g cherished idea has r e c e n t l y proved t o be p o s s i b l e (Refs. 9,lO).
I t ought, i n p r i n c i p l e , t o be p o s s i b l e t o t a k e a r e a c t i o n o f i n t e r e s t and t o compute t h e t r a n s i t i o n s t a t e . p o s s i b l y by t h e use o f s i m i l a r i t y techniques. bound t o a p r o t e i n and serve as a hapten a g a i n s t which a n t i b o d i e s may be r a i s e d . Since these a n t i b o d i e s a r e p r o t e i n s which b i n d t o t h e t r a n s i t i o n s t a t e o f t h e o r i g i n a l r e a c t i o n t h e y should a c t as enzymes o r 'abzyrnesl as they have been dubbed (Ref. 11).
As described above t h e t r a n s i t i o n s t a t e i s then modelled t o y i e l d a s t a b l e analogue The t r a n s i t i o n s t a t e analogue may then be
CONCLUSIONS
Many o f t h e t o p i c s discussed here a r e p e r f e c t l y s t r a i g h t f o r w a r d , i n p r i n c i p l e , b u t demand massive computational investment. The advent o f t h e new generation o f supercomputers and t h e impact o f t h e t r a n s p u t e r discussed i n o t h e r p a r t s o f t h i s meeting l e a d t o f i r m confidence t h a t t h e r e w i l l be a massive upsurge o f a c t i v i t y i n t h e use o f quantum chemistry i n drug design.
